In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Medivance completes $16mm private placement

Executive Summary

Medivance (therapeutic temperature management) has completed a $16mm Series B private placement to lead investors Cross Atlantic Partners and Camden Partners. Existing investors Skyline Ventures, Partisan Management Group, and Kimberly Clark Ventures also took part in the financing. New investors included CSFB Private Equity, New England Venture Partners, and Nikko Synergy Ventures. The company surpassed its original goal of $10mm.
Deal Industry
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register